Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder of Endocrine Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT06148636
What this trial is testing

A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Tumor of the LungNeuroendocrine Tumor Grade 1+2 more
David Bushnell 24
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Testing effectiveness (Phase 2)Looking for participantsNCT01174121
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more
National Cancer Institute (NCI) 332
Large-scale testing (Phase 3)Study completedNCT01497938
What this trial is testing

Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature

Who this might be right for
Type 1 Diabetes
Medtronic MiniMed, Inc. 247
Large-scale testing (Phase 3)Study completedNCT00785421
What this trial is testing

Chemotherapy With or Without Enoxaparin in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CONKO-Studiengruppe 312
Not applicableUnknownNCT02944006
What this trial is testing

Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling

Who this might be right for
Pancreas Cancer
Seoul National University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT03738787
What this trial is testing

Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy

Who this might be right for
Pancreatic FistulaPancreatic NeoplasmsPostoperative Complications
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 40
Early research (Phase 1)Study completedNCT02009449
What this trial is testing

Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company 353
Large-scale testing (Phase 3)Ended earlyNCT01836432
What this trial is testing

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Carcinoma Non-resectableLocally Advanced Malignant Neoplasm
NewLink Genetics Corporation 302
Testing effectiveness (Phase 2)Ended earlyNCT01240304
What this trial is testing

A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Arkansas 10
Testing effectiveness (Phase 2)Study completedNCT03008304
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fuda Cancer Hospital, Guangzhou 20
Early research (Phase 1)Study completedNCT01383538
What this trial is testing

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinomaPancreatic Neoplasms
Andrew Ko 15
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)WithdrawnNCT04130399
What this trial is testing

Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Adenocarcinoma
Indiana University
Early research (Phase 1)WithdrawnNCT05043987
What this trial is testing

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerGastric Cancer
Conjupro Biotherapeutics, Inc.
Not applicableStudy completedNCT04741152
What this trial is testing

Blinded Resection in Case of the Pancreatic Insulinoma

Who this might be right for
Insulinoma; Pancreas
Vishnevsky Center of Surgery 197
Not applicableStudy completedNCT06582849
What this trial is testing

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

Who this might be right for
Bone CancerBrain CancerColorectal Cancer+24 more
Washington University School of Medicine 33
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Not applicableStudy completedNCT02241187
What this trial is testing

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 2
Not applicableNot Yet RecruitingNCT06310993
What this trial is testing

Exercise to Boost Immunity in Advanced Cancer

Who this might be right for
Mesothelioma; LungPancreatic Cancer
Sheffield Teaching Hospitals NHS Foundation Trust 30
Next Page